Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ampion for Knee Osteoarthritis Pain
NCT01839331Phase 2Completed
- Sponsor
- Ampio Pharmaceuticals, Inc.
- Start
- Mar 2013
- Primary completion
- Aug 2013
- Modality
- Small Molecules, Cyclic Peptides
01
Overview
A Phase 2 trial of aspartyl-alanyl-diketopiperazine in osteoarthritis (OA), sponsored by Ampio Pharmaceuticals, Inc.. Started Mar 2013; status: completed.
02
Drugs
aspartyl-alanyl-diketopiperazine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01839331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01839331.